Exact Mass: 296.1518
Exact Mass Matches: 296.1518
Found 88 metabolites which its exact mass value is equals to given mass value 296.1518,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Panaxydol chlorohydrin
10-chloro-3,9-Dihydroxyheptadec-1-en-4,6-diyne
Panaxydol chlorohydrin is found in tea. Panaxydol chlorohydrin is isolated from Korean ginseng root. Isolated from Korean ginseng root. Panaxydol chlorohydrin is found in tea.
6-allyl-8b-Carboxy-ergoline
(2S,7S)-6-(prop-2-en-1-yl)-6,11-diazatetracyclo[7.6.1.0²,⁷.0¹²,¹⁶]hexadeca-1(16),9,12,14-tetraene-4-carboxylic acid
6-allyl-8b-Carboxy-ergoline is a metabolite of cabergoline. Cabergoline (brand names Dostinex and Cabaser), an ergot derivative, is a potent dopamine receptor agonist on D2 receptors. In vitro, rat studies show cabergoline has a direct inhibitory effect on pituitary lactotroph cells. It is frequently used as a first-line agent in the management of prolactinomas due to higher affinity for D2 receptor sites, less severe side effects, and more convenient dosing schedule than the older bromocriptine. (Wikipedia)
C10-DATS (TENTATIVE)
C10-DATS (TENTATIVE)
TENTATIVELY IDENTIFIED SPECTRUM ONLY!!!!!!!!!; Extracted (without noise removal) from HAL_N: mz295_14_rt16_23_HCD60_C10-DATS; CONFIDENCE Tentative identification: isomers possible (Level 3)
8-Methyl-3-methoxy-6,8,13,13a-tetrahydro-5H-isoquino[2,1-b][2,7]naphthyridin-2-ol
8-Methyl-3-methoxy-6,8,13,13a-tetrahydro-5H-isoquino[2,1-b][2,7]naphthyridin-2-ol
(+)-kopsihainanine A|(1S,3R,4aR,11cS)-3,4,5,6,7,11c-hexahydro-3-hydroxy-1,4a-propano-4aH-pyrido[3,2-c]carbazol-2(1H)-one|kopsihainanine A
(+)-kopsihainanine A|(1S,3R,4aR,11cS)-3,4,5,6,7,11c-hexahydro-3-hydroxy-1,4a-propano-4aH-pyrido[3,2-c]carbazol-2(1H)-one|kopsihainanine A
12, 13-Dihydro, Ac-(3E, 6S, 7S, 9Z, 12Z)-7-Chloro-3, 9, 12-pentadecatrien-1-yn-6-ol
12, 13-Dihydro, Ac-(3E, 6S, 7S, 9Z, 12Z)-7-Chloro-3, 9, 12-pentadecatrien-1-yn-6-ol
8-Acetoxymethyl-6-methyl-8,9-didehydro-ergolin|8-acetoxymethyl-6-methyl-8,9-didehydro-ergoline|elymoclavine acetate|Elymodavine-acetate|O-acetyl-elymoclavine|O-Acetylelymoclavin
8-Acetoxymethyl-6-methyl-8,9-didehydro-ergolin|8-acetoxymethyl-6-methyl-8,9-didehydro-ergoline|elymoclavine acetate|Elymodavine-acetate|O-acetyl-elymoclavine|O-Acetylelymoclavin
5-tert-Butyl 1-ethyl 3-aminopyrrolo[3,4-c]pyrazole-1,5(4H,6H)-dicarboxylate
5-tert-Butyl 1-ethyl 3-aminopyrrolo[3,4-c]pyrazole-1,5(4H,6H)-dicarboxylate
3-aminomethyl-2-cbz-1,2,3,4-tetrahydro-isoquinoline
3-aminomethyl-2-cbz-1,2,3,4-tetrahydro-isoquinoline
3,5-di-tert-butyl-4-hydroxybenzenepropanoyl chloride
3,5-di-tert-butyl-4-hydroxybenzenepropanoyl chloride
Guanethidine sulfate
Guanethidine monosulfate
D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D013565 - Sympatholytics C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents
(R)-BENZYL METHYL(1,2,3,4-TETRAHYDROQUINOLIN-3-YL)CARBAMATE
(R)-BENZYL METHYL(1,2,3,4-TETRAHYDROQUINOLIN-3-YL)CARBAMATE
1-methyl-1-phenyl-N,N-bis(trimethylsilyl)-Silanediamine
1-methyl-1-phenyl-N,N-bis(trimethylsilyl)-Silanediamine
Ethyl 4-[[(ethylphenylamino)methylene]amino]benzoate
Ethyl 4-[[(ethylphenylamino)methylene]amino]benzoate
7-tert-Butyl 3-ethyl 5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazine-3,7(8H)-dicarboxylate
7-tert-Butyl 3-ethyl 5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazine-3,7(8H)-dicarboxylate
4-[3-(4-aminocyclohexa-1,3-dien-1-yl)oxyphenoxy]cyclohexa-1,3-dien-1-amine
4-[3-(4-aminocyclohexa-1,3-dien-1-yl)oxyphenoxy]cyclohexa-1,3-dien-1-amine
1-[1-(tert-butoxycarbonyl)piperidin-4-yl]-1H-1,2,3-triazole-4-carboxylic acid
1-[1-(tert-butoxycarbonyl)piperidin-4-yl]-1H-1,2,3-triazole-4-carboxylic acid
l-Glutamic acid, N-coco acyl derivs., compds. with triethanolamine (1:1)
l-Glutamic acid, N-coco acyl derivs., compds. with triethanolamine (1:1)
[1-[3-(4-Methylphenoxy)propyl]-2-benzimidazolyl]methanol
[1-[3-(4-Methylphenoxy)propyl]-2-benzimidazolyl]methanol
1-(2,3-dihydro-1H-inden-5-yl)-3-(2-ethoxyphenyl)urea
1-(2,3-dihydro-1H-inden-5-yl)-3-(2-ethoxyphenyl)urea
(Furan-2-yl)[4-(3-phenylallyl)piperazin-1-yl]methanone
(Furan-2-yl)[4-(3-phenylallyl)piperazin-1-yl]methanone
1-(2-Methoxyethyl)-2-[(4-methylphenoxy)methyl]benzimidazole
1-(2-Methoxyethyl)-2-[(4-methylphenoxy)methyl]benzimidazole
N-[(2S,3S,6R)-6-(2-aminoethyl)-2-(hydroxymethyl)oxan-3-yl]-2-fluorobenzamide
N-[(2S,3S,6R)-6-(2-aminoethyl)-2-(hydroxymethyl)oxan-3-yl]-2-fluorobenzamide
N-[(2S,3S,6S)-6-(2-aminoethyl)-2-(hydroxymethyl)oxan-3-yl]-2-fluorobenzamide
N-[(2S,3S,6S)-6-(2-aminoethyl)-2-(hydroxymethyl)oxan-3-yl]-2-fluorobenzamide
N-[(2R,3R,6S)-6-(2-aminoethyl)-2-(hydroxymethyl)-3-oxanyl]-2-fluorobenzamide
N-[(2R,3R,6S)-6-(2-aminoethyl)-2-(hydroxymethyl)-3-oxanyl]-2-fluorobenzamide
N-[(2R,3S,6R)-6-(2-aminoethyl)-2-(hydroxymethyl)-3-oxanyl]-2-fluorobenzamide
N-[(2R,3S,6R)-6-(2-aminoethyl)-2-(hydroxymethyl)-3-oxanyl]-2-fluorobenzamide
N-[(2R,3S,6S)-6-(2-aminoethyl)-2-(hydroxymethyl)-3-oxanyl]-2-fluorobenzamide
N-[(2R,3S,6S)-6-(2-aminoethyl)-2-(hydroxymethyl)-3-oxanyl]-2-fluorobenzamide
N-[(2S,3R,6S)-6-(2-aminoethyl)-2-(hydroxymethyl)-3-oxanyl]-2-fluorobenzamide
N-[(2S,3R,6S)-6-(2-aminoethyl)-2-(hydroxymethyl)-3-oxanyl]-2-fluorobenzamide
N-[(2R,3R,6R)-6-(2-aminoethyl)-2-(hydroxymethyl)-3-oxanyl]-2-fluorobenzamide
N-[(2R,3R,6R)-6-(2-aminoethyl)-2-(hydroxymethyl)-3-oxanyl]-2-fluorobenzamide
N-[(2S,3R,6R)-6-(2-aminoethyl)-2-(hydroxymethyl)-3-oxanyl]-2-fluorobenzamide
N-[(2S,3R,6R)-6-(2-aminoethyl)-2-(hydroxymethyl)-3-oxanyl]-2-fluorobenzamide
(5Z)-3a-Hydroxy-5-[(E)-2-methylbut-2-enylidene]-1-phenyl-3,6-dihydro-2H-pyrrolo[2,3-b]pyridin-4-one
(5Z)-3a-Hydroxy-5-[(E)-2-methylbut-2-enylidene]-1-phenyl-3,6-dihydro-2H-pyrrolo[2,3-b]pyridin-4-one
(2-{[3-(3,4-Dihydroxy-5-methoxyphenyl)prop-2-enoyl]oxy}ethyl)trimethylazanium
(2-{[3-(3,4-Dihydroxy-5-methoxyphenyl)prop-2-enoyl]oxy}ethyl)trimethylazanium
(1S,7R,14S)-9-hydroxy-15,17-diazatetracyclo[12.2.2.13,7.18,12]icosa-3(20),4,8,10,12(19)-pentaen-6-one
(1S,7R,14S)-9-hydroxy-15,17-diazatetracyclo[12.2.2.13,7.18,12]icosa-3(20),4,8,10,12(19)-pentaen-6-one
4-Ethylthio-5-methyl-9-(3-oxobutyl)-2-oxatricyclo(4.4.0.0(4,9))decan-3-one
4-Ethylthio-5-methyl-9-(3-oxobutyl)-2-oxatricyclo(4.4.0.0(4,9))decan-3-one
SN40
SN40
SN40 is a potent amino acid transport (AAT) inhibitor with Kis of 7.29 μM, 2.42 μM, 2.94 μM, 5.55 μM, 24.43 μM and 5.55 μM for rat ASCT2, human ASCT2, EAAT1, EAAT2, EAAC1 and EAAT5, respectively. SN40 can be used for researching anticancer[1].
(8r,9s,10r)-10-chloroheptadec-16-en-4,6-diyne-8,9-diol
(8r,9s,10r)-10-chloroheptadec-16-en-4,6-diyne-8,9-diol
(1s,12s,13r,17r)-3,19-dimethyl-15-oxa-3,19-diazapentacyclo[10.6.1.0²,¹⁰.0⁴,⁹.0¹³,¹⁷]nonadeca-2(10),4,6,8-tetraen-16-one
(1s,12s,13r,17r)-3,19-dimethyl-15-oxa-3,19-diazapentacyclo[10.6.1.0²,¹⁰.0⁴,⁹.0¹³,¹⁷]nonadeca-2(10),4,6,8-tetraen-16-one
(3s,9r,10s)-10-chloroheptadec-1-en-4,6-diyne-3,9-diol
(3s,9r,10s)-10-chloroheptadec-1-en-4,6-diyne-3,9-diol
(2r,3r,4r,9r)-4-hydroxy-8,8-dimethyl-7,16-diazapentacyclo[9.6.1.0²,⁹.0³,⁷.0¹⁵,¹⁸]octadeca-1(17),11(18),12,14-tetraen-6-one
(2r,3r,4r,9r)-4-hydroxy-8,8-dimethyl-7,16-diazapentacyclo[9.6.1.0²,⁹.0³,⁷.0¹⁵,¹⁸]octadeca-1(17),11(18),12,14-tetraen-6-one
(1r,13s,16r)-16-hydroxy-5,14-diazapentacyclo[12.3.3.0¹,¹³.0⁴,¹².0⁶,¹¹]icosa-4(12),6,8,10-tetraen-15-one
(1r,13s,16r)-16-hydroxy-5,14-diazapentacyclo[12.3.3.0¹,¹³.0⁴,¹².0⁶,¹¹]icosa-4(12),6,8,10-tetraen-15-one
(3z,6s,7s,9z)-7-chloropentadeca-3,9-dien-1-yn-6-yl acetate
(3z,6s,7s,9z)-7-chloropentadeca-3,9-dien-1-yn-6-yl acetate
8-methoxy-13-methyl-5a,10,11,13-tetrahydro-5h-2,12-diazatetraphen-7-ol
8-methoxy-13-methyl-5a,10,11,13-tetrahydro-5h-2,12-diazatetraphen-7-ol
13-oxa-4,20-diazatetracyclo[12.2.2.2³,⁶.1⁸,¹²]henicosa-1(16),8,10,12(19),14,17-hexaen-11-ol
13-oxa-4,20-diazatetracyclo[12.2.2.2³,⁶.1⁸,¹²]henicosa-1(16),8,10,12(19),14,17-hexaen-11-ol
(3e,6s,7s,9z)-7-chloropentadeca-3,9-dien-1-yn-6-yl acetate
(3e,6s,7s,9z)-7-chloropentadeca-3,9-dien-1-yn-6-yl acetate
(3s,6s)-13-oxa-4,20-diazatetracyclo[12.2.2.2³,⁶.1⁸,¹²]henicosa-1(16),8,10,12(19),14,17-hexaen-11-ol
(3s,6s)-13-oxa-4,20-diazatetracyclo[12.2.2.2³,⁶.1⁸,¹²]henicosa-1(16),8,10,12(19),14,17-hexaen-11-ol
(1s,3s,4r,5r)-1-[(2r,3s,5r)-3,5,6-trihydroxy-2-methyloxan-3-yl]hexane-1,3,4,5-tetrol
(1s,3s,4r,5r)-1-[(2r,3s,5r)-3,5,6-trihydroxy-2-methyloxan-3-yl]hexane-1,3,4,5-tetrol
(5as,13r)-8-methoxy-13-methyl-5a,10,11,13-tetrahydro-5h-2,12-diazatetraphen-7-ol
(5as,13r)-8-methoxy-13-methyl-5a,10,11,13-tetrahydro-5h-2,12-diazatetraphen-7-ol
(2-hydroxy-2-{[3-(4-hydroxy-3-methoxyphenyl)prop-2-enoyl]oxy}ethyl)trimethylazanium
(2-hydroxy-2-{[3-(4-hydroxy-3-methoxyphenyl)prop-2-enoyl]oxy}ethyl)trimethylazanium
n-(4-{[hydroxy(phenyl)methylidene]amino}butyl)benzenecarboximidic acid
n-(4-{[hydroxy(phenyl)methylidene]amino}butyl)benzenecarboximidic acid
4-hydroxy-8,8-dimethyl-7,16-diazapentacyclo[9.6.1.0²,⁹.0³,⁷.0¹⁵,¹⁸]octadeca-1(17),11(18),12,14-tetraen-6-one
4-hydroxy-8,8-dimethyl-7,16-diazapentacyclo[9.6.1.0²,⁹.0³,⁷.0¹⁵,¹⁸]octadeca-1(17),11(18),12,14-tetraen-6-one
